US bishops: FDA approval of generic abortion drug is a ‘shocking inconsistency’

US bishops: FDA approval of generic abortion drug is a ‘shocking inconsistency’ Robert F. Kennedy Jr., U.S. President Trump's nominee to be secretary of Health and Human Services, testifies at his confirmation hearing before the Senate Finance Committee Jan. 29, 2025, on Capitol Hill in Washington. (OSV News photo/Evelyn Hockstein, Reuters)

The US Catholic bishops sharply criticised the Trump administration’s recent approval of the generic abortion drug mifepristone, saying that women and children deserve better care. The Food and Drug Administration (FDA) approved the drug even as the administration is currently investigating the abortion drug for safety concerns. US Secretary of Health and Human Services Robert…

Click here to subscribe